PURPOSEWith the broad use of next-generation sequencing assays, it has become clear that mutations in DNA repair genes are more commonly found than previously reported. In advanced prostate cancer ...
CITATION STYLE
von Werdt, A., Brandt, L., Schärer, O. D., & Rubin, M. A. (2021). PARP Inhibition in Prostate Cancer With Homologous Recombination Repair Alterations. JCO Precision Oncology, (5), 1639–1649. https://doi.org/10.1200/po.21.00152
Mendeley helps you to discover research relevant for your work.